Figure 2
Figure 2. Defects in splenic and BM B-cell development in KA/KA mice. (A) Analysis of the total splenic B-cell population of WT and KA/KA mice at 6 weeks of age using flow cytometry with the indicated B-cell surface markers B220+CD90.1+, B220+CD19+, B220+IgM+, B220+IgD+, CD21+CD23− (B220+ gate), and CD21loCD23hi (B220+ gate). Numbers are the percentage of the cell population; MZ, marginal zone; FO, follicular. (B) Analysis of BM cells isolated from WT and KA/KA mice at 6 weeks of age using flow cytometry with B-cell and progenitor-cell markers. A combination of markers was used to define pre-pro-B cells (B220+CD43hiCD19−BP1−CD24loIgM−), pro-B cells (B220+CD43medBP-1+CD19+ IgM−), and pre-B cells (B220hiCD43−CD19+IgM−).

Defects in splenic and BM B-cell development in KA/KA mice. (A) Analysis of the total splenic B-cell population of WT and KA/KA mice at 6 weeks of age using flow cytometry with the indicated B-cell surface markers B220+CD90.1+, B220+CD19+, B220+IgM+, B220+IgD+, CD21+CD23 (B220+ gate), and CD21loCD23hi (B220+ gate). Numbers are the percentage of the cell population; MZ, marginal zone; FO, follicular. (B) Analysis of BM cells isolated from WT and KA/KA mice at 6 weeks of age using flow cytometry with B-cell and progenitor-cell markers. A combination of markers was used to define pre-pro-B cells (B220+CD43hiCD19BP1CD24loIgM), pro-B cells (B220+CD43medBP-1+CD19+ IgM), and pre-B cells (B220hiCD43CD19+IgM).

Close Modal

or Create an Account

Close Modal
Close Modal